109 related articles for article (PubMed ID: 7700912)
1. 4-Hydroperoxycyclophosphamide treatment of stored bone marrow grafts.
Davis JM; Schepers KG; Noga SJ; Jones RJ
Prog Clin Biol Res; 1994; 389():3-7. PubMed ID: 7700912
[No Abstract] [Full Text] [Related]
2. The effect of PIXY-321 on 4-hydroperoxycyclophosphamide purged and CD34+ positively selected bone marrow.
Hami LS; Shpall EJ; Johnston CS; Berenson R; Jones RB
Prog Clin Biol Res; 1992; 377():321-5. PubMed ID: 1279709
[No Abstract] [Full Text] [Related]
3. Effect of Ethiofos on cytotoxicity of pharmacological purging protocols used for autologous marrow grafts in acute lymphoblastic leukemia.
Skala JP; Rogers PC; Chan KW; Rodriguez WC
Prog Clin Biol Res; 1992; 377():57-62. PubMed ID: 1332075
[No Abstract] [Full Text] [Related]
4. Purging with 4-hydroperoxycyclophosphamide combinations.
Jones RJ; Miller CB; Rowley SD
Prog Clin Biol Res; 1992; 377():1-9; discussion 10-1. PubMed ID: 1438406
[No Abstract] [Full Text] [Related]
5. Evaluation of the protection of murine bone marrow stem cells by WR-2721 during in vitro treatment with mafosfamide.
Jiang R; Bony V; Lopez M
Prog Clin Biol Res; 1994; 389():23-9. PubMed ID: 7700906
[No Abstract] [Full Text] [Related]
6. Effects of mafosfamide on the clonogenic cells in precursor B acute lymphoblastic leukemia: significance for ex vivo purging of bone marrow.
Kramer B; Makrynikola V; Bradstock K
Prog Clin Biol Res; 1992; 377():41-7. PubMed ID: 1438438
[No Abstract] [Full Text] [Related]
7. Immunopharmacologic purging of breast cancer from bone marrow for autologous bone marrow transplantation.
Shpall EJ; Anderson IC; Bast RC; Joines WT; Jones RB; Ross M; Edwards S; Eggleston S; Johnston C; Tepperberg M
Prog Clin Biol Res; 1990; 333():321-35; discussion 336. PubMed ID: 2308989
[No Abstract] [Full Text] [Related]
8. Purging of myeloma cells from bone marrow using monoclonal antibodies and magnetic immunobeads in combination with 4-hydroperoxycyclophosphamide.
Shimazaki C; Inaba T; Murakami S; Fujita N; Nakagawa M; Gulati SC; Fried J; Clarkson BD; Wisniewolski R; Wang CY
Prog Clin Biol Res; 1990; 333():311-9. PubMed ID: 2308988
[No Abstract] [Full Text] [Related]
9. In vitro purging of human rhabdomyosarcoma cells using 4-hydroperoxycyclophosphamide.
Ozkaynak MF; Nolta J; Parkman R
Cancer Res; 1990 Mar; 50(5):1455-8. PubMed ID: 2302710
[TBL] [Abstract][Full Text] [Related]
10. In vitro active cyclophosphamide derivatives in cleansing procedures intended for autologous bone marrow transplantation.
Manna A; Sparaventi G; Palazzi M; Porcellini A
Haematologica; 1986; 71(3):257-61. PubMed ID: 3093332
[No Abstract] [Full Text] [Related]
11. Bone marrow micrometastases in chemotherapy-responsive advanced breast cancer: effect of ex vivo purging with 4-hydroperoxycyclophosphamide.
Passos-Coelho J; Ross AA; Davis JM; Huelskamp AM; Clarke B; Noga SJ; Davidson NE; Kennedy MJ
Cancer Res; 1994 May; 54(9):2366-71. PubMed ID: 8162582
[TBL] [Abstract][Full Text] [Related]
12. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide.
Ratajczak MZ; Ratajczak J; Kuczynski W; Light B; Lusk EJ; Gewirtz AM
Exp Hematol; 1993 Dec; 21(13):1663-7. PubMed ID: 8243568
[TBL] [Abstract][Full Text] [Related]
13. T-cell depletion from allogeneic bone marrow by counterflow centrifugation is not associated with a substantial loss of CD34-positive cells.
Preijers F; Ruijs P; Schattenberg A; de Witte T
Prog Clin Biol Res; 1994; 389():339-44. PubMed ID: 7535440
[No Abstract] [Full Text] [Related]
14. Use of amifostine in bone marrow purging.
Cagnoni PJ; Jones RB; Bearman SI; Ross M; Hami L; Franklin WA; Capizzi R; Schein PS; Shpall EJ
Semin Oncol; 1996 Aug; 23(4 Suppl 8):44-8. PubMed ID: 8783666
[TBL] [Abstract][Full Text] [Related]
15. Deferoxamine as a purging agent for autologous bone marrow grafts in neuroblastoma.
Skala JP; Rogers PC; Chan KW; Chao HY; Rodriguez WC
Prog Clin Biol Res; 1992; 377():71-8. PubMed ID: 1438447
[No Abstract] [Full Text] [Related]
16. Purging with 4-hydroperoxycyclophosphamide.
Jones RJ
J Hematother; 1992; 1(4):343-8. PubMed ID: 1345676
[TBL] [Abstract][Full Text] [Related]
17. A simple method to detect immature hemopoietic progenitors after in vitro treatment with ASTA-Z 7654.
Lamana M; Gonzalez R; Camara R; Steegmann JL; Fernandez-Rañada JM
Prog Clin Biol Res; 1992; 377():35-9. PubMed ID: 1438430
[No Abstract] [Full Text] [Related]
18. In vitro purging of bone marrow with mafosfamide synergizes with in vivo chemotherapy to delay the hematological recovery in a murine model of autologous bone marrow transplantation.
Lopez M; Mary JY; Sainteny F
Exp Hematol; 1993 Feb; 21(2):311-8. PubMed ID: 8425567
[TBL] [Abstract][Full Text] [Related]
19. Antisense oligonucleotide OL (1) p53 for in vitro purging of autologous bone marrow in acute myelogenous leukemia.
Bishop MR; Warkentin PI; Jackson JD; Bayever E; Iversen PL; Whalen VI; Lastovica J; Haines K; Kessinger A
Prog Clin Biol Res; 1994; 389():183-7. PubMed ID: 7700901
[No Abstract] [Full Text] [Related]
20. Bone marrow transplantation with major ABO blood group incompatibility using automated removal of red blood cells from incompatible bone marrow by CS 3000 plus.
O-Charoen R; Soiprasert P; Chaisiripoomkere W; Jootar S; Chiewsilp P
Transplant Proc; 1994 Aug; 26(4):2352-3. PubMed ID: 8066772
[No Abstract] [Full Text] [Related]
[Next] [New Search]
